 |
 |

Phobia Study Criteria-Reply
Donald F. Klein, MD;
Donald C. Ross, PhD
New York State Psychiatric Institute Columbia University College of Physicians and Surgeons New York
Margaret G. Woerner, PhD;
Charlotte Marker Zitrin, MD
Department of Psychiatry Long Island Jewish-Hillside Medical Center Box 38 Glen Oaks, NY 11004
Arch Gen Psychiatry. 1983;40(10):1150.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
In Reply.—
We thank Dr Snaith for the opportunity to remedy an omission from our article. We accepted no patient into our study who had previously received an antidepressant treatment. Therefore, Dr Snaith's advice to exclude drug-treated patients is correct with regard to our published article, but is irrelevant to our actual study. In any case, his point is more relevant to the study by Marks et al since our subjects showed a benefit from drug treatment.
With regard to the relationship of chronicity to treatment effect, Dr Snaith raised a researchable question. We are currently reviewing our data for predictors of drug effect. If we had not included patients with such "vast ranges of duration," we would not have been able to deal with this issue. Therefore, we think our study does make some sense, if only to afford the opportunity of testing Dr Snaith's hypothesis. Our initial analyses showed
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|